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growth factor (VEGF) expression through
regulating snail of human oral cancerYi-Ling Yu a, Ching-Ping Wang e, Yi-Hao Chang e,
Seng-sheen Fan a,b, Wei-Ting Chao a,b, Chih-Hsin Tang f,
Min-Huan Wu b,c,da Department of Life Science, Tunghai University, Taichung, Taiwan
b Life Science Research Center, Tunghai University, Taichung, Taiwan
c Physical Education Office, Tunghai University, Taichung, Taiwan
d Sports Recreation and Health Management Continuing Studies, Tunghai University, Taichung, Taiwan
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Taichung, Taiwan
f Graduate Institute of Basic Medical Science, China Medical University, Taichung, TaiwanBackground: Oral cancer is one of the major causes of mortality in humans, and squamous cell carcinoma is the most
common type of oral cancer. Endothelin-1 (ET-1) has been implicated in tumor angiogenesis and metastasis. However, the
relationship of ET-1 with vascular endothelial growth factor (VEGF) expression in human oral cells is mostly unknown.
Materials and Methods: ET-1-mediated VEGF expression was assessed by qPCR and Western blot analysis. The mechanisms
of action of ET-1 in different signaling pathways were studied using Western blotting. Knockdown of proteins was achieved
by siRNA transfection.
Results: ET-1 increased VEGF expression through ETAR, integrin-linked kinase (ILK), Akt and sanil signaling cascades.
Knockdown of ET-1 decreased VEGF expression and also abolished oral cancer conditional medium-mediated angiogenesis
in vitro.
Discussion: Taken together, these results indicate that ET-1 occurs through ETAR, ILK and Akt, which in turn activates snail,
resulting in the activation of VEGF expression in human oral cancer.http://dx.doi.org/10.1016/j.bgm.2014.09.010
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